Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
Clinical trial NCT07308886 · RECRUITING
Trial details
- NCT number
- NCT07308886
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-08
- Primary completion
- 2036-01-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.